MedTrace Logo

Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser Therapy

NCT07521462 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-04-13

No results posted yet for this study

Summary

The aim of this clinical study is to evaluate the effectiveness and safety of a dermocosmetic product in reducing facial redness and visible blood vessels associated with erythematotelangiectatic rosacea.

Investigators will compare the dermocosmetic product to a placebo applied to opposite sides of the face, when used alone and in combination with laser treatment.

Participants will apply the products twice daily for 2 month followed by continued use in combination with laser treatment, and will attend regular clinical visits for assessments and questionnaires.

Conditions

  • Rosacea, Erythematotelangiectatic
  • Rosacea Subtype 1 (Erythematotelangiectatic)

Interventions

OTHER

Dermocosmetic tested product

The dermocosmetic product will be applied topically to one side of the face twice daily.

OTHER

Placebo

The placebo is a dermocosmetic formulation identical in appearance, texture, and application to the active product but without active ingredients. It is applied topically to the opposite side of the face twice daily, following the same regimen as the active product.

DEVICE

Vascular laser treatment

Participants receive three sessions of vascular laser treatment performed at regular intervals during the study. Laser therapy is used as part of standard care to target facial redness and visible blood vessels. The dermocosmetic product and placebo continue to be applied as adjunct treatments during this phase.

Sponsors & Collaborators

  • ISISPHARMA

    lead INDUSTRY

Principal Investigators

  • Olivia BAUVIN, Doctor of Medicine · Department of Dermatology and Venereology, Charles-Nicolle Hospital, Rouen, FRANCE

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-06-30
Completion
2027-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07521462 on ClinicalTrials.gov